Key paediatric milestone reached in Dimerix’s kidney-disease drug trial

Key findings could boost Dimerix’s rare kidney disease drug trial

stockhead.com.au - 28/Oct 19:35

Medical collab PARASOL has broadened potential surrogate endpoints for FDA approval of treatments for a rare kidney disease treatment, potentially ...

ASX Quarterly Health Wrap: Action for Dimerix Phase 3 kidney trial

stockhead.com.au - 31/Oct 18:55

Dimerix, Paradigm and Blinklab are among ASX health companies reporting quarterly results this week. ...

Responsible diamond sourcing programme achieves record growth

miningandminerals.co.za - 25/Oct 06:19

De Beers Group announced recently that its GemFair programme – the first-of-its-kind responsible sourcing programme – has achieved record growth...

Combination therapy shows promising results in treating stage 3 melanoma

news.medical.net - 01/Nov 21:11

Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of patients with stage 3...

First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist

drugs.com - 22/Oct 22:10

AACHEN, Germany, Oct. 22, 2024 . Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical...

Evergreen Theragnostics opens trial of 68Ga─EVG321 for patients with small cell lung cancer in European Union

pharmabiz.com - 21/Oct 19:03

Evergreen Theragnostics, Inc., a clinical─stage radiopharmaceutical company, focused on providing additional treatment options for cancer patients,...